QSAM Biosciences
  • About
    • Our Story
    • Leadership
    • Contact Us
  • Technology
    • CycloSam®
    • Publications
  • Pipeline
    • Metastatic Bone Cancers
    • Osetosarcoma/Ewing’s Sarcoma
    • Bone Marrow Ablation
  • Investors
    • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Forward-Looking Statements
    • Code of Ethics
  • Investors
  • About
  • Technology
  • Pipeline
  • Investors

Governance Documents

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Governance

  • Overview
  • Board of Directors
  • Board Committees
  • Governance Documents

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Corporate Governance

Download Nominating and Corporate Governance

Policy on Insider Trading

Download Policy on Insider Trading

Code of Ethics

Download Code of Ethics
  • Email Alerts
  • Contacts
  • RSS News Feed
Return to main site

Contact Us

  • info@qsambio.com
  • (512) 343-4558
  • 9442 N Capital of Texas Hwy, Plaza 1, Ste 500 Austin, TX 78759

© Copyright 2023 QSAM Biosciences, Inc. | All Rights Reserved. | Privacy Policy | Terms 
Cyclosam® is a registered trademark of IGL Pharma, Inc., a development partner of QSAM Therapeutics, Inc.